We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets close in 5 hrs 17 mins

Forward Pharma A/S (FWP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.85-0.13 (-4.52%)
As of 10:40AM EDT. Market open.
Full screen
Previous Close2.98
Open2.98
Bid2.83 x 3000
Ask2.89 x 800
Day's Range2.69 - 2.98
52 Week Range1.63 - 30.00
Volume22,597
Avg. Volume150,570
Market Cap134.248M
Beta2.46
PE Ratio (TTM)0.15
EPS (TTM)19.44
Earnings DateNov 27, 2017 - Dec 1, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2017-09-12
1y Target Est37.00
Trade prices are not sourced from all markets
  • ACCESSWIRE21 days ago

    Today's Research Reports on Trending Tickers: Geron and Forward Pharma

    NEW YORK, NY / ACCESSWIRE / May 23, 2018 / U.S. markets fell Tuesday on geopolitical concerns after President Trump stated he was not happy with the current U.S. – China trade talks. The Dow Jones Industrial ...

  • GlobeNewswirelast month

    Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent

    Forward Pharma A/S (FWP) (“We” or “Forward” or the “Company”), today announced the filing of a notice of appeal of the decision of the Opposition Division of the European Patent Office (the “EPO”) that revoked EP2801355 (the “’355 patent”), written reasons for which were received on March 22, 2018. The notice was filed to the Technical Board of Appeal (the “TBA”) of the EPO. “With the notice of appeal filed, we officially initiate the process to get the decision of the Opposition Division overturned and have the ‘355 patent reinstated,” said Dr. Claus Bo Svendsen, Chief Executive Officer of Forward.

  • GlobeNewswirelast month

    Forward Pharma Reports Full-Year 2017 Financial and Operational Results

    COPENHAGEN, Denmark, April 30, 2018-- Forward Pharma A/S, today reported financial results for the year ended December 31, 2017. Net income for the year ended December 31, 2017 was $917.1 million, or $2.30 ...

  • Best-In-Class Undervalued Stocks
    Simply Wall St.7 months ago

    Best-In-Class Undervalued Stocks

    Stocks, such as SandRidge Mississippian Trust I and Hudson Technologies, are trading at a value below what they may actually be worth. There’s a few ways you can determine howRead More...